| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENHA | Enhanced Group Inc. | Apeiron Investment Group . Ltd | Director | Sep 02, 2026 | Buy | $1.58 | 107,693 | 169,627 | 37,058,644 | Sep 04, 2026, 04:30 PM | |
| ENHA | Enhanced Group Inc. | Apeiron Investment Group . Ltd | Director | Sep 03, 2026 | Buy | $1.58 | 25,414 | 40,152 | 37,084,058 | Sep 04, 2026, 04:30 PM | |
| ENHA | Enhanced Group Inc. | Apeiron Investment Group . Ltd | Director | Aug 18, 2026 | Buy | $1.70 | 93,000 | 158,212 | 35,276,635 | Aug 20, 2026, 07:30 AM | |
| ENHA | Enhanced Group Inc. | Apeiron Investment Group . Ltd | Director | Aug 19, 2026 | Buy | $1.66 | 1,674,316 | 2,778,446 | 36,950,951 | Aug 20, 2026, 07:30 AM | |
| ENHA | Enhanced Group Inc. | Apeiron Investment Group . Ltd | Director | Aug 17, 2026 | Buy | $1.65 | 200,000 | 330,420 | 33,062,812 | Aug 18, 2026, 08:55 AM | |
| ENHA | Enhanced Group Inc. | Apeiron Investment Group . Ltd | Director | Aug 14, 2026 | Buy | $1.97 | 150,000 | 295,620 | 32,862,812 | Aug 17, 2026, 06:10 AM | |
| ANRO | Alto Neuroscience, Inc. | Apeiron Investment Group . Ltd | See Remarks | Feb 06, 2024 | Conversion | - | 251,881 | - | 251,881 | Mar 06, 2024, 09:15 AM | |
| ANRO | Alto Neuroscience, Inc. | Apeiron Investment Group . Ltd | See Remarks | Feb 06, 2024 | Conversion | - | 674,658 | - | 674,658 | Mar 06, 2024, 09:15 AM | |
| SNSE | Sensei Biotherapeutics, Inc. | Apeiron Investment Group . Ltd | 10% Owner | Jun 01, 2023 | Sale | $1.58 | 955,738 | 1,510,066 | 0 | Jun 02, 2023, 05:03 PM | |
| SNSE | Sensei Biotherapeutics, Inc. | Apeiron Investment Group . Ltd | 10% Owner | Jun 01, 2023 | Sale | $1.58 | 2,485,923 | 3,927,758 | 0 | Jun 02, 2023, 05:03 PM | |
| SNSE | Sensei Biotherapeutics, Inc. | Apeiron Investment Group . Ltd | 10% Owner | Feb 23, 2023 | Buy | $1.61 | 2,200 | 3,539 | 2,485,923 | Feb 27, 2023, 08:10 PM |
